GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Solvonis Therapeutics PLC (LSE:SVNS) » Definitions » Sale Of Property, Plant, Equipment

Solvonis Therapeutics (LSE:SVNS) Sale Of Property, Plant, Equipment : £0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Solvonis Therapeutics Sale Of Property, Plant, Equipment?

Solvonis Therapeutics's sale of property, plant, equipment for the three months ended in Sep. 2024 was £0.00 Mil. It means Solvonis Therapeutics gained £0.00 Mil from selling property, plant, and equipment. Solvonis Therapeutics's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Sep. 2024 was £0.00 Mil.

Compared with last quarter (£0.00 Mil in Jun. 2024 ), Solvonis Therapeutics gained the same money from selling property, plant, and equipment in Sep. 2024 (£0.00 Mil).

Solvonis Therapeutics Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Solvonis Therapeutics's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solvonis Therapeutics Sale Of Property, Plant, Equipment Chart

Solvonis Therapeutics Annual Data
Trend May18 May19 May20 May21 Dec22 Dec23
Sale Of Property, Plant, Equipment
Get a 7-Day Free Trial - - - - -

Solvonis Therapeutics Quarterly Data
May18 May19 May20 May21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
Sale Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Solvonis Therapeutics Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solvonis Therapeutics Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Solvonis Therapeutics's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Solvonis Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Solvonis Therapeutics PLC (LSE:SVNS) » Definitions » Sale Of Property, Plant, Equipment
Comparable Companies
LSE:EQT LSE:SNT LSE:XSG XTER:SIE XPAR:SU ETN PH OSTO:ATCO A ITW EMR TSE:7011 XTER:ENR CMI OTIS AME XSWX:SCHN IR ROK OHEL:KNEBV XYL
Traded in Other Exchanges
J4I:Germany
Address
Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF
Website
https://www.solvonis.com
Solvonis Therapeutics PLC, formerly Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment. The Company operates in two business segments being polymer development and production in Slovenia.

Solvonis Therapeutics Headlines

No Headlines